Medibank share price lifts despite shareholder class action

The health insurer has been hit with another class action relating to its 2022 cyber-attack.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points
  • The Medibank share price is gaining 0.76% to trade at $3.295 right now
  • That's despite news the company is facing a shareholder class action
  • The action alleges Medibank breached continuous disclosure obligations and ASX listing rules 

The Medibank Private Ltd (ASX: MPL) share price is in the green on Thursday despite the company facing a shareholder class action.

It comes on the back of a massive cyber-attack that saw the data of 9.7 million Australians in the hands of hackers late last year.

Right now, the Medicare share price is $3.295, 0.76% higher than its previous close.

For comparison, the S&P/ASX 200 Index (ASX: XJO) has gained 0.97% at the time of writing.

Let's take a closer look at the latest news from the ASX 200 health insurance giant.

a woman in a business suit stands with her arms folded in the background of a statue of lady justice wearing robes, carrying a sword and holding the scales of justice.

Image source: Getty Images

Medibank faces shareholder class action

The Medibank share price appears not to have been impacted by news a shareholder class action against the company has been filed in the Supreme Court of Victoria.

The action alleges the company breached continuous disclosure obligations and ASX listing rules by not disclosing information related to alleged deficiencies in its cyber security systems.

Medibank intends to defend the action, understood to have been brought on behalf of investors who bought shares in Medibank between July 2019 and October 2022.

The law firm behind the legal action is United States-based Quinn Emanuel.

Medibank revealed it had been served with the action after the market closed on Wednesday.

The ASX 200 company bore $26.2 million of costs related to the cyber-attack last half.

It expects to fork out another $13.8 million to $18.8 million this half. That's before any potential remediation, regulatory, or litigation costs.

The shareholder class action is the second suit faced by the company as a result of the breach.

Medicare vowed to defend itself against a class action brought on behalf of current and former customers last month. It included allegations of breach of contract, contraventions of Australian consumer law, and breach of equitable obligations of confidence.

It was filed in the Federal Court of Australia and brought by law firm Baker McKenzie, funded by Omni Bridgeway.

Medibank share price snapshot

The Medibank share price tumbled 18% when the company revealed the cyber-attack in October, and it hasn't quite recovered yet. It remains 6% lower than it was prior to its ill-fated announcement.

Though, it has gained 6% over the last 12 months and 13% so far this year.

Comparatively, the ASX 200 has gained 3% year to date and has fallen 5% since this time last year.

Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

Five healthcare workers standing together and smiling.
Healthcare Shares

3 ASX 200 healthcare shares to buy amid sector rout

The experts are backing these stocks for price growth.

Read more »

Researchers and doctors with futuristic 3D hologram overlay for body anatomy or DNA in hospital clinic.
Healthcare Shares

Are investors taking a big gamble chasing 4DX shares higher and higher?

Investor interest in this ASX healthcare tech stock is booming.

Read more »

A group of people in a corporate setting do a collective high five.
Broker Notes

3 reasons to buy Ramsay Health Care shares today

A leading analyst expects Ramsay Health Care shares to keep outperforming in the months ahead.

Read more »

Half a man's face from the nose up peers over a table.
Healthcare Shares

If I could buy only 1 ASX 200 share right now, it would be…

This stock looks underpriced and oversold to me.

Read more »

woman testing substance in laboratory dish, csl share price
Healthcare Shares

CSL shares slide again in March — but is a comeback brewing?

Brokers remain upbeat and see upside up to 95% for the biotech stock.

Read more »

A female athlete in green spandex leaps from one cliff edge to another representing 3 ASX shares that are destined to rise and be great
Broker Notes

Up 57% since February, why Telix shares could keep leaping higher in 2026

A leading analyst believes investors are undervaluing Telix shares. But why?

Read more »

A woman has a thoughtful look on her face as she studies a fan of Australian 20 dollar bills she is holding on one hand while he rest her other hand on her chin in thought.
Healthcare Shares

Is it time to get greedy with CSL shares?

This ASX healthcare giant is out of favour, but that may be where opportunity starts.

Read more »

Stressed, unhappy, and tired scientist with a headache working on a computer in a lab.
Healthcare Shares

3 ASX 200 healthcare shares at multi-year lows

Does this present a buying opportunity?

Read more »